JUMPSEAT
AEROSPACE NEWS

Defense Health Agency Wins Award for Canine Plasma Breakthrough

Key Takeaways
  • Defense Health Agency team wins program management award
  • First-ever FDA clearance for canine freeze-dried plasma
  • Product is shelf-stable and portable
  • Team overcame complex manufacturing and regulatory hurdles
Sign in to view key takeaways Get full access to in-depth analysis and key takeaways.
Sign In
Silver membership required Upgrade to Silver to access Key Takeaways.
Upgrade
Strategic Implications

This achievement may indicate a significant advancement in medical care for military working dogs, suggesting a potential shift in the way trauma-induced blood loss is treated in austere environments. The success of the Canine Freeze-Dried Plasma program could have broader implications for the development of life-saving products for human use, and may set a precedent for future collaborations between the Defense Health Agency and commercial partners.

Sign in to view strategic implications Get full access to strategic analysis and expert insights.
Sign In
Silver membership required Upgrade to Silver to access Strategic Implications.
Upgrade

What Happened

Team Secures FDA Clearance for Life-Saving Product

A team from the Defense Health Agency has been recognized with a program management award for securing FDA clearance for a life-saving product for military working dogs. The Canine Freeze-Dried Plasma (cFDP) Integrated Product Team successfully navigated complex manufacturing and regulatory hurdles to deliver a shelf-stable, portable product that can be administered at the point of injury. This breakthrough may have significant implications for the treatment of trauma-induced blood loss in austere environments. The award was announced during the Military Health System Research Symposium in Kissimmee, Florida, and was first reported by Unknown Source.

Source | Originally Published: August 11, 2026

Advertisement 728 × 90
JUMPSEAT
AEROSPACE NEWS
JUMPSEAT
AEROSPACE NEWS

Defense Health Agency Wins Award for Canine Plasma Breakthrough

Sponsored by: Jumpseat Solutions
Key Takeaways
  • Defense Health Agency team wins program management award
  • First-ever FDA clearance for canine freeze-dried plasma
  • Product is shelf-stable and portable
  • Team overcame complex manufacturing and regulatory hurdles
Sign in to view key takeaways Get full access to in-depth analysis and key takeaways.
Sign In
Silver membership required Upgrade to Silver to access Key Takeaways.
Upgrade
Strategic Implications

This achievement may indicate a significant advancement in medical care for military working dogs, suggesting a potential shift in the way trauma-induced blood loss is treated in austere environments. The success of the Canine Freeze-Dried Plasma program could have broader implications for the development of life-saving products for human use, and may set a precedent for future collaborations between the Defense Health Agency and commercial partners.

Sign in to view strategic implications Get full access to strategic analysis and expert insights.
Sign In
Silver membership required Upgrade to Silver to access Strategic Implications.
Upgrade

What Happened

Team Secures FDA Clearance for Life-Saving Product

A team from the Defense Health Agency has been recognized with a program management award for securing FDA clearance for a life-saving product for military working dogs. The Canine Freeze-Dried Plasma (cFDP) Integrated Product Team successfully navigated complex manufacturing and regulatory hurdles to deliver a shelf-stable, portable product that can be administered at the point of injury. This breakthrough may have significant implications for the treatment of trauma-induced blood loss in austere environments. The award was announced during the Military Health System Research Symposium in Kissimmee, Florida, and was first reported by Unknown Source.

Source | Originally Published: August 11, 2026

Advertisement 300 × 250 Google AdSense